Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria T Abreu

Showing results (131-140 of 219) with videos related to

Pageof 22
Sort By:
Gastroenterology|August 2, 2003
6-thioguanine can cause serious liver injury in inflammatory bowel disease patientsMarla C Dubinsky, Eric A Vasiliauskas, Hardeep Singh, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 14, 2005
Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitisMasayuki Fukata, Kathrin S Michelsen, Rajaraman Eri, et al.
Clinical and Translational Gastroenterology|April 14, 2017
Genetic Characterization and Influence on Inflammatory Bowel Disease Expression in a Diverse Hispanic South Florida CohortOriana M Damas, Lissette Gomez, Maria A Quintero, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 26, 2010
Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injuryDavid Hsu, Masayuki Fukata, Yasmin G Hernandez, et al.
Journal of Crohn'S & Colitis|September 10, 2022
Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPablo A Olivera, Juan S Lasa, Ignacio Zubiaurre, et al.
Gastroenterology|July 27, 2023
Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation StudyAndres J Yarur, Alexandra Bruss, Andrea Moosreiner, et al.
Therapeutic Advances in Gastroenterology|March 31, 2022
Social barriers influence inflammatory bowel disease (IBD) outcomes and disproportionally affect Hispanics and non-Hispanic Blacks with IBDOriana M Damas, Gabriela Kuftinec, Nidah S Khakoo, et al.
Gut|April 26, 2017
Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine inductionShiran Gerassy-Vainberg, Alexandra Blatt, Yael Danin-Poleg, et al.
Gastro Hep Advances|December 15, 2023
Colorectal Cancer Immunotherapy: State of the Art and Future DirectionsAlyssa Mauri Cornista, Maria Virginia Giolito, Kristi Baker, et al.
BMC Medical Genetics|May 10, 2011
Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control studyInga Peter, Adele A Mitchell, Laurie Ozelius, et al.
Pageof 22

Showing results (131-140 of 219) with videos related to

Sort By:
Pageof 22
Gastroenterology|August 2, 2003
6-thioguanine can cause serious liver injury in inflammatory bowel disease patientsMarla C Dubinsky, Eric A Vasiliauskas, Hardeep Singh, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 14, 2005
Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitisMasayuki Fukata, Kathrin S Michelsen, Rajaraman Eri, et al.
Clinical and Translational Gastroenterology|April 14, 2017
Genetic Characterization and Influence on Inflammatory Bowel Disease Expression in a Diverse Hispanic South Florida CohortOriana M Damas, Lissette Gomez, Maria A Quintero, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 26, 2010
Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injuryDavid Hsu, Masayuki Fukata, Yasmin G Hernandez, et al.
Journal of Crohn'S & Colitis|September 10, 2022
Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPablo A Olivera, Juan S Lasa, Ignacio Zubiaurre, et al.
Gastroenterology|July 27, 2023
Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation StudyAndres J Yarur, Alexandra Bruss, Andrea Moosreiner, et al.
Therapeutic Advances in Gastroenterology|March 31, 2022
Social barriers influence inflammatory bowel disease (IBD) outcomes and disproportionally affect Hispanics and non-Hispanic Blacks with IBDOriana M Damas, Gabriela Kuftinec, Nidah S Khakoo, et al.
Gut|April 26, 2017
Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine inductionShiran Gerassy-Vainberg, Alexandra Blatt, Yael Danin-Poleg, et al.
Gastro Hep Advances|December 15, 2023
Colorectal Cancer Immunotherapy: State of the Art and Future DirectionsAlyssa Mauri Cornista, Maria Virginia Giolito, Kristi Baker, et al.
BMC Medical Genetics|May 10, 2011
Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control studyInga Peter, Adele A Mitchell, Laurie Ozelius, et al.
Pageof 22